| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 22 |
| 1 | CLOPIDOGREL BISULFATE | 21 |
| 2 | ASPIRIN 325 MG | 20 |
| 3 | ASPIRIN 81 MG | 20 |
| 4 | CLOPIDOGREL | 19 |
| 5 | RIVAROXABAN | 16 |
| 6 | CARVEDILOL | 12 |
| 7 | APIXABAN | 10 |
| 8 | OMEPRAZOLE | 10 |
| 9 | OMEPRAZOLE MAGNESIUM | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 1 | 0.0019 |
| 1 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 2 | LIDOCAINE HCL | 3 | 0.0012 |
| 3 | GINKGO BILOBA | 1 | 0.0007 |
| 4 | TENECTEPLASE | 1 | 0.0006 |
| 5 | DIPYRIDAMOLE | 2 | 0.0005 |
| 6 | ACETAZOLAMIDE SODIUM | 3 | 0.0005 |
| 7 | GEMFIBROZIL | 5 | 0.0004 |
| 8 | FLUVOXAMINE MALEATE | 1 | 0.0004 |
| 9 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 29 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 3 | P2Y12 Platelet Inhibitor [EPC] | 18 |
| 4 | beta-Adrenergic Blocker [EPC] | 14 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| 6 | Corticosteroid [EPC] | 12 |
| 7 | alpha-Adrenergic Blocker [EPC] | 12 |
| 8 | Proton Pump Inhibitor [EPC] | 10 |
| 9 | Insulin Analog [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 2 | Carbonic Anhydrase Inhibitor [EPC] | 4 | 0.0002 |
| 3 | P2Y12 Platelet Inhibitor [EPC] | 18 | 0.0002 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 7 | 0.0001 |
| 5 | Factor Xa Inhibitor [EPC] | 29 | 0.0001 |
| 6 | Ester Local Anesthetic [EPC] | 5 | 0.0001 |
| 7 | Amide Local Anesthetic [EPC] | 8 | 0.0001 |
| 8 | alpha-Adrenergic Blocker [EPC] | 12 | 0.0001 |
| 9 | Antiarrhythmic [EPC] | 8 | 0.0001 |